AHS Conference Coverage
AHS Conference Coverage
06/04/2026
Anthony Calabro, MA
Basic Science Award recipient Alberto Ouro, PhD, presented his team’s cross-sectional study at the American Headache Society 68th Annual Scientific Meeting in Orlando, FL. The award recognizes the top basic...
06/04/2026
AHS Conference Coverage
AHS Conference Coverage
06/04/2026
Anthony Calabro, MA
Basic Science Award recipient Alberto Ouro, PhD, presented his team’s cross-sectional study at the American Headache Society 68th Annual Scientific Meeting in Orlando, FL. The award recognizes the top basic...
06/04/2026
AHS Conference Coverage
AHS Conference Coverage
06/04/2026
Anthony Calabro, MA
Basic Science Award recipient Alberto Ouro, PhD, presented his team’s cross-sectional study at the American Headache Society 68th Annual Scientific Meeting in Orlando, FL. The award recognizes the top basic...
06/04/2026
AHS Conference Coverage
AHS Conference Coverage
06/04/2026
Anthony Calabro, MA
A 1-year interim analysis of a phase 3, multicenter, open-label, 156-week extension study found overall reductions in systolic and diastolic blood pressure with atogepant 60 mg once daily in persons with...
06/04/2026
AHS Conference Coverage
AHS Conference Coverage
06/04/2026
Anthony Calabro, MA
A 1-year interim analysis of a phase 3, multicenter, open-label, 156-week extension study found overall reductions in systolic and diastolic blood pressure with atogepant 60 mg once daily in persons with...
06/04/2026
AHS Conference Coverage
AHS Conference Coverage
06/04/2026
Anthony Calabro, MA
A 1-year interim analysis of a phase 3, multicenter, open-label, 156-week extension study found overall reductions in systolic and diastolic blood pressure with atogepant 60 mg once daily in persons with...
06/04/2026
AHS Conference Coverage
AHS Conference Coverage
06/04/2026
Anthony Calabro, MA
A 1-year interim analysis of a phase 3, multicenter, open-label, 156-week extension study found overall reductions in systolic and diastolic blood pressure with atogepant 60 mg once daily in persons with...
06/04/2026
AHS Conference Coverage
AHS Conference Coverage
06/04/2026
Anthony Calabro, MA
A 1-year interim analysis of a phase 3, multicenter, open-label, 156-week extension study found overall reductions in systolic and diastolic blood pressure with atogepant 60 mg once daily in persons with...
06/04/2026
AHS Conference Coverage
AHS Conference Coverage
06/04/2026
Anthony Calabro, MA
A 1-year interim analysis of a phase 3, multicenter, open-label, 156-week extension study found overall reductions in systolic and diastolic blood pressure with atogepant 60 mg once daily in persons with...
06/04/2026
AHS Conference Coverage
AHS Conference Coverage
06/04/2026
Anthony Calabro, MA
In an Early Career Lecture Award study presented at the American Headache Society 68th Annual Scientific Meeting, nitroglycerin provoked headache and vestibular symptoms in participants with definite...
06/04/2026